This site is intended for healthcare professionals
News

Novartis acquires Vedere Bio and photoreceptor-protein-based optogenetic therapies.

Read time: 1 mins
Last updated:30th Oct 2020
Published:30th Oct 2020
Type: industry
Register free for full access to medthority.com